Cargando…
Estimation of treatment effects following a sequential trial of multiple treatments
When a clinical trial is subject to a series of interim analyses as a result of which the study may be terminated or modified, final frequentist analyses need to take account of the design used. Failure to do so may result in overstated levels of significance, biased effect estimates and confidence...
Autores principales: | Whitehead, John, Desai, Yasin, Jaki, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217198/ https://www.ncbi.nlm.nih.gov/pubmed/32207166 http://dx.doi.org/10.1002/sim.8497 |
Ejemplares similares
-
Estimation in multi‐arm two‐stage trials with treatment selection and time‐to‐event endpoint
por: Brückner, Matthias, et al.
Publicado: (2017) -
GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic
por: Whitehead, John, et al.
Publicado: (2017) -
Factorial versus multi‐arm multi‐stage designs for clinical trials with multiple treatments
por: Jaki, Thomas, et al.
Publicado: (2016) -
Correction: GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic
por: Whitehead, John, et al.
Publicado: (2018) -
Point estimation following a two-stage group sequential trial
por: Grayling, Michael J, et al.
Publicado: (2022)